I
n humans apolipoprotein (apo) A-IV is synthesized primarily in the intestine as a 46-kd glycoprotein. 1 After isolation of lipoproteins by ultracentrifugation, most of the apoA-IV in plasma is found in the lipoprotein-free fraction, and only small amounts have been detected in chylomicrons, very-low-density lipoproteins, and high-density lipoproteins (HDLs).
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3 Sizeexclusion chromatography shows that up to 70% of plasma apoA-IV is bound to HDL, 4 which suggests that reported distributions may be an artifact of the ultracentrifugation technique and that apoA-IV is loosely bound to lipoprotein particles.
The precise function of apoA-IV is still unknown. Its intestinal origin and experimental evidence from familial apoA-I/C-III/A-IV deficiency, a rare genetic mutation, suggest that it plays a role in dietary fat absorption and chylomicron synthesis. 5 In vitro studies show that the activation of lipoprotein lipase by apoC-II is mediated by apoA-IV 6 and that apoA-FV can serve as an activator of lecithinxholesterol acyltransferase (LCAT). 78 ApoA-IV-containing lipoproteins promote cholesterol efflux women, 7% lowering was observed in both 12 apoA-IV (1/2) subjects and 48 apoA-IV (1/1) subjects. ApoA-FV phenotype had a significant effect on plasma high-density lipoprotein cholesterol levels during both dietary periods; women carrying the apoA-IV-2 allele had higher levels than those homozygous for the apoA-IV-1 allele. The opposite was true for triglyceride levels, but only during the period when the subjects consumed the high-fat, high-cholesterol diet. These data indicated that apoA-IV phenotype modulates the LDL-C-lowering response to a diet meeting NCEP step 1 criteria in men and that high-density lipoprotein cholesterol and triglyceride levels are affected by this locus in women. Key Words • apolipoprotein A-IV • genetic polymorphism • diet • low-fat diets • LDL from cultured fibroblasts 9 and adipose cells in vitro, 10 and there is evidence that apoA-IV may be one of the ligands for the putative HDL receptor. 1011 Therefore, the data suggest that apoA-IV plays a role in fat absorption and reverse cholesterol transport.
Genetically determined isoforms of apoA-IV have been detected in humans and other mammalian species.
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Using isoelectric focusing and immunoblotting, eight isoforms (apoA-IV-0 through apoA-IV-7) have been detected. 1523 The most common isoform in all populations studied is apoA-FV-1, with an allele frequency in Caucasians ranging from .88 to .95. 15 -24 ApoA-IV-2 (Gln^^His) is the second most common isoform, with an allele frequency of approximately .05 to .12 in Caucasians 24 ; this allele appears to be less common in other races.
-

25
- 26 The other isoforms are rare and in some cases restricted to a particular ethnic group. 17 > 25 - 26 Additional variation within these isoforms has been detected by using the porymerase chain reaction. A relatively common mutation (Thr 347 ->Ser) has been documented in subjects with the apoA-IV-1 isoform, and similar heterogeneity has been detected in subjects with the apoA-IV-0 and apoA-FV-3 isoforms.
27
- 28 The effect of apoA-FV genetic variation on plasma lipid levels has been studied in several populations. 15 -27 -2931 In some population studies in Caucasians, the apoA-IV-2 allele is associated with higher levels of HDL cholesterol (HDL-C) and/or lower triglyceride levels, 24 -31 -32 but no associations have been observed in other Studies. 18, We examined the effect of apoA-IV isoforms on plasma lipid and lipoprotein response to switching from a high-fat, high-cholesterol diet to a low-fat, low-cholesterol diet. Our results are consistent with the concept that the presence of the apoA-IV-2 allele is associated with decreased plasma low-density lipoprotein cholesterol (LDL-C) lowering in response to reduction in dietary saturated fat and cholesterol intake in men and with higher HDL-C levels in women. Table 1 ; these have been described in detail. 36 - 40 There were 140 Caucasians, 9 African Americans, 2 Hispanics, 1 Asian, and 1 American Indian. All women were postmenopausal. Due to the significant differences observed between men and women for age and lipoprotein levels at baseline, data for men and women were analyzed separately.
Methods Subjects
Diets and Experimental Protocols
Subjects at the different sites followed a similar dietary protocol consisting of two diet periods ranging from 4 through 24 weeks each: a high-fat (39.3 ±2.6% [mean±SD] of total calories; range, 35.4 to 40.7), high-saturated fat (14.5%; range, 12.9 to 15.2), high-cholesterol (435±97 mg/d; range, 306 to 510) (HFHC) diet period; and a low-fat (26.4±5.1% of total calories; range, 18.9 to 29.7), low-saturated fat (7.6%; range, 4.4 to 9.9), low-cholesterol (201+22 mg/d; range, 178 to 230) (LFLC) diet period ( Table 2) .
At the Boston site, the experimental protocol was approved by the Human Investigation Review Committee of the New England Medical Center and Tufts University. In this protocol, all the food was provided for the subjects. The first phase was a 6-week period during which subjects consumed a diet approximating that of the current American diet (baseline). The second phase was a 24-week period during which subjects consumed a low-fat, low-cholesterol diet conforming to the National Cholesterol Education Program (NCEP) step 2 recommendations. 37 ' 38 All diets were prepared in the Metabolic Research Unit (MRU) kitchen at the USDA Human Nutrition Research Center on Aging at Tufts University and were composed entirely of natural foods consumed as three meals and one snack per day. Subjects were required to report to the MRU a minimum of five times per week and to eat at least one meal per visit at the unit. All food and drink were packaged for takeout. During each visit body weight and blood pressure were measured. Calorie levels were assigned so that the subjects neither gained nor lost weight. The Grand Forks database (GRAND, release 8606) was used to calculate the nutrient composition of the diets, and analytical data from All nutrient values except cholesterol are expressed as percent energy, and in some cases, constituent fatty acids do not have the same content as total fat due to computer analysis and rounding.
Hazelton Laboratories were used as confirmation. The percent energy distribution of the baseline diet was as follows: 15±1.2% protein, 49.4±2.2% carbohydrate, 35.5±2.3% fat (14.1±2.2% saturated, 14.5±1.0% monounsaturated, and 6.9±1.2% polyunsaturated), and 147±27 mg cholesterol per 4.184 kJ. During consumption of the NCEP step 2 diet, the percent energy distribution was as follows: 17±0.9% protein, 56.1±2.9% carbohydrate, 25.9±1.4% fat (4.2±0.5% saturated, 11.2±0.9% monounsaturated, and 10.4±0.2% polyunsaturated), and 53±13 mg cholesterol per 4.184 kJ. A total of 36 subjects (18 women and 18 men; mean age, 62±11 years) were studied at the Boston site.
At the Beltsville site, the protocol was approved by the Institutional Review Boards of the National Cancer Institute, National Institutes of Health, and Georgetown University School of Medicine. Each diet period lasted 10 weeks. All meals were prepared from commonly available foods in the MRU kitchen at the Beltsville Human Nutrition Research Center. On weekdays, breakfast and dinner were eaten in the facility and take-out lunches were provided. Weekend meals were prepackaged for home consumption. The high-fat diet contained 41% of calories as fat (15% saturated fatty acids, 14% oleic acid, and 8% linoleic acid), 14.8% protein, 45.8% carbohydrates, and 189 mg cholesterol per 4.184 kJ. The low-fat diet contained 19% of calories from fat (4.4% saturated fatty acids, 6.5 oleic acid, and 5.2% linoleic acid), 17.1% protein, 67.3% carbohydrate, and 76 mg cholesterol per 4.184 kJ. At this site 43 male subjects were studied (mean age, 34±9 years). 36 The protocol at the Dallas site was approved by the Institutional Review Boards of both the University of Texas Southwestern Medical Center and the Veterans Administration Center at Dallas. The experimental approach here was somewhat different. The high-fat diet was consumed for 1 month and the low-fat diet for 3 through 4 months. Diet counseling was provided for each phase with the intent of increasing or decreasing the fat and cholesterol content of the diets. After each initial counseling session, subjects were telephoned once during both the first and second week of each dietary period to answer questions and to verify compliance. Final assessment of diet consumption was determined from the subjects' written 7-day food records, which were analyzed by COMPUTRITION, the computerized database of the National Research Council's nutrient content of foods (Computrition, Inc). The high-fat diet contained 40% of calories as fat (15% saturated fatty acids, 15% monounsaturated fatty acids, and 9% polyunsaturated fatty acids), 17% protein, 43% carbohydrates, and 170 mg cholesterol per 4.184 kJ. The low-fat diet contained 30% of calories from fat (10% saturated fatty acids, 8% monounsaturated fatty acids, and 12% polyunsaturated fatty acids), 19% protein, 51% carbohydrates, and 120 mg cholesterol per 4.184 kJ. Seventy-four subjects were studied at this site (32 men and 42 women; mean age, 58±10 years).
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Lipid and Lipoprotein Analysis and ApoA-IV Phenotyping
Blood samples were collected after a 12-hour fast in 0.1% EDTA during the last week of each study period. Total cholesterol and triglycerides were determined at each site using enzymatic reagents. 41 Assays were standardized through participation in the Centers for Disease Control and Prevention-National Heart, Lung, and Blood Institute Standardization Program.
ApoA-IV phenotyping was performed at the Boston site by isoelectric focusing of whole plasma followed by immunoblotting 32 using a specific anti-human apoA-IV antiserum.
Statistical Analysis
The SAS program (SAS Institute) was used to perform statistical analyses. The t test and ANOVA for repeated measurements were used for comparing continuous variables. Due to sample size, subjects with the less common phenotypes (apoA-IV [3/1] and apoA-IV [1/0]) were not included in the statistical analysis. Triglyceride levels were not normally distributed and were logarithmically transformed before analysis. Untransformed data are presented in the tables and figures.
Results
The distribution of apoA-IV phenotypes in our population is shown in Table 3 . The relative frequencies of the apoA-IV (1/1) and apoA-IV (1/2) phenotypes were .81 and .19, respectively. No significant differences were noted between phenotypes for age or BMI in either men or women; however, women were significantly older than men (62.7±7.0 versus 46.8±15.4 years, / > <.0001), and their mean total cholesterol, LDL-C, and HDL-C levels were also higher (/><.01; Table 1 ). Plasma levels and percent changes in total cholesterol and triglycerides (Table 3) and LDL-C and HDL-C (Table 4 ) are shown for subjects with different apoA-IV phenotypes. Consumption of the LFLC diet induced significant decreases (P<.05) in plasma total cholesterol, LDL-C, and HDL-C in both men and women. These decreases remained significant after analyzing each of the phenotypes separately (Tables 3 and 4) . Plasma triglyceride concentrations were not significantly affected by diet changes (Table 3) .
In men consuming the HFHC diet, apoA-FV (1/2) and apoA-IV (1/1) individuals had similar triglyceride, total cholesterol, LDL-C, and HDL-C levels. Consumption of an LFLC diet induced decreases of 0.83 and 0.65 mmol/L for total cholesterol and LDL-C, respectively, in apoA-IV (1/1) men. In apoA-IV (1/2) men these decreases were 0.59 and 0.31 mmol/L, respectively (P<.005). Hence, reductions in total cholesterol and LDL-C levels after consumption of the LFLC were significantly lower (P<.005) in subjects carrying the apoA-IV (1/2) phenotype (5.32 and 3.80 mmol/L, respectively) compared with those carrying the apoA-IV (1/1) phenotype (5.07 and 3.47 mmol/L). This effect was seen in the Beltsville and Dallas sites, which contributed 6 and 8 apoA-IV (1/2) subjects, respectively, but not in the Boston site, possibly due to the low prevalence of apoA-IV (1/2) subjects in the latter site (n=3). In women, total cholesterol and LDL-C did not differ between phenotypes; however, during both diet periods, mean HDL-C levels were significantly higher (P<. When those subjects carrying the E4 allele were removed from the statistical analysis, the significance of the observed effect on LDL-C response to dietary alteration did not change (Table 5) . ApoA-IV (1/2) men had a significantly lower response than apoA-IV (1/1) men (-0.22 versus -0.60 mmol/L, respectively). No significant phenotype effects were observed in women.
Discussion
There is an increased awareness in Western societies of the need to lower plasma cholesterol levels to decrease the high prevalence of coronary heart disease. To achieve this purpose, the current recommendations for the general population are to limit dietary fat to ^30% of calories, saturated fat to <10%, and cholesterol to <300 mg/d (NCEP step 1). In subjects who are still hypercholesterolemic on this diet, further restriction of saturated fat to <7% of calories and cholesterol to <200 mg/d (NCEP step 2) is recommended before the use of medication. 42 The therapeutic diets used in Boston and Beltsville met NCEP step 2 criteria, while diets used in Dallas met NCEP step 1 criteria.
The extent of the response to changes in the amount or type of dietary fat and cholesterol varies among individuals.
4345 In some individuals the cholesterol level decreases considerably following a low-fat diet; in others it remains unchanged. The serum lipoprotein response to dietary manipulation may have a strong genetic component; most of the evidence has been gathered from animal studies 4649 because this hypothesis is difficult to prove in humans. Several studies have focused on the effect of genetic variation at the apoE locus on response of plasma lipid levels to changes in dietary fat and cholesterol, 5055 but this issue has not been addressed with regard to apoA-IV isoforms until recently. The present study and the work of McCombs et al 56 indicate that apoA-IV phenotype may influence individual lipoprotein responsiveness to dietary alterations. 57 In our study, total cholesterol, LDL-C, and HDL-C levels decreased significantly after consumption of the LFLC diet. The magnitude of LDL-C lowering was twice as great in men as in women, which agrees with observations by other investigators.
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- 58 In a large study of 4587 subjects placed on a low-fat, low-cholesterol diet for a 3-week period, the mean reduction in LDL-C was 25% in men and 19% in women, also indicating a somewhat greater responsiveness in male than female subjects. 58 However, most of the women in this investigation were studied on an NCEP step 1 diet, whereas the men were studied on both NCEP step 1 and step 2 diets. At the Dallas site, mean LDL-C reductions were 6% in women and 8% in men; at the Beltsville site, in contrast, only men were studied on an NCEP step 2 diet, and the mean LDL-C reduction was 20%. At the Boston site, on an NCEP step 2 diet, the LDL-C reduction was 14% for both men and women. Thus, within-site data comparisons show similar reductions for men and women.
When the effect of apoA-IV phenotype on diet responsiveness was examined, our data indicated that the LDL-C lowering observed in apoA-IV (1/2) men at 7% was significantly less than that observed in apoA-IV (1/1) men at 16%. Moreover, these differences in response were seen at both the Beltsville and Dallas sites, where the LDL-C lowering in apoA-IV (1/2) men was less than that predicted by the equation of Hegsted et al, 59 whereas the response in apoA-IV (1/1) men was greater than the value predicted (Table 6 ). These differences were not seen in Boston, but there were only three apoA-IV (1/2) men at this site (Table 5 ). In women no significant differences between phenotypes were observed. This may be due to the lower dietary response and/or a smaller number of female subjects in the study.
The apoE4 allele has been shown to increase the plasma LDL-C response to dietary fat and cholesterol changes. 51 -3355 To account for this possible confounder, we analyzed this population after removing all subjects carrying the apoE4 phenotype. In this subgroup, the effect of the apoA-IV-2 allele remained significant after removing the influence of the apoE-4 allele.
ApoA-IV phenotype had a significant effect on plasma HDL-C levels during both dietary periods, with women carrying the apoA-IV-2 allele having higher levels than those homozygous for the apoA-IV-1 allele. The opposite was true for triglyceride levels, but only during the period when the subjects consumed the HFHC diet. These findings agree with some 61 In this study no differences were observed between apoA-IV phenotypes for age and BMI, and the addition of these variables to the analysis did not affect the significance of the results. Serum apoA-IV levels are significantly and positively correlated with both the percent of total daily caloric intake ingested as dietary fat and the levels of plasma triglyceride.
62
- 63 Metabolic studies show that the fractional catabolic rate of the apoA-IV-2 variant is significantly slower than that of the apoA-FV-1 variant. 64 ApoA-IV-2 has more a-helical structure, is more stable in solution, and is more hydrophobic than apoA-IV-1. These structural differences are associated with a higher affinity for lipids due to an increased ability to penetrate phospholipid surfaces. Additionally, apoA-IV-2 has been shown to increase the catalytic efficiency of LCAT activation, 65 although a more recent observation contradicts this finding. 66 Whether the apoA-IV-2 variant is associated with altered modulation of lipoprotein lipase by apoC-II remains to be determined. All these data suggest that subjects carrying the apoA-IV-2 variant may handle dietary fat differently from those subjects homozygous for the most common variant, apoA-IV-1.
Our data indicate that the apoA-IV phenotype modulates the LDL-C-lowering response to diet in men and that HDL-C and triglyceride levels are affected by this locus in women.
